XML 25 R8.htm IDEA: XBRL DOCUMENT v3.20.4
CONSOLIDATED STATEMENTS OF EQUITY - USD ($)
$ in Thousands
Total ATNI Stockholders' Equity
Cumulative Effect, Period of Adoption, Adjustment
Total ATNI Stockholders' Equity
Common Stock
Treasury Stock, at cost
Additional Paid In Capital
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
Retained Earnings
Accumulated Other Comprehensive Income/(Loss)
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Income/(Loss)
Non-Controlling Interests
Cumulative Effect, Period of Adoption, Adjustment
Non-Controlling Interests
Cumulative Effect, Period of Adoption, Adjustment
Total
Balance, beginning of period at Dec. 31, 2017 $ 1,490 $ 688,727 $ 170 $ (36,110) $ 167,973 $ 1,693 $ 552,948 $ (203) $ 3,746 $ 1,146 $ 141,496 $ 2,636 $ 830,223
Increase (Decrease) in Stockholders' Equity                          
Issuance of restricted shares of common stock   2 2                   2
Issuance of shares of common stock upon exercise of stock options   6,319     6,319               6,319
Purchase of shares of common stock   (12,437)   (12,437)                 (12,437)
Stock-based compensation   6,420     6,420               6,420
Dividends declared on common stock   (10,863)         (10,863)           (10,863)
Distributions to non-controlling interests                     (19,033)   (19,033)
Repurchase of non-controlling interests   1,066     1,066           (10,729)   (9,663)
Comprehensive income:                          
Net income (loss)   19,815         19,815       15,057   34,872
Other comprehensive income (loss)   (5,152)             (5,152)       (5,152)
Comprehensive income   14,663                 15,057   29,720
Balance, end of period at Dec. 31, 2018   695,387 172 (48,547) 181,778   563,593   (1,609)   127,937   823,324
Increase (Decrease) in Stockholders' Equity                          
Issuance of shares of common stock upon exercise of stock options   771     771               771
Purchase of shares of common stock   (2,582)   (2,582)                 (2,582)
Stock-based compensation   5,922     5,922           462   6,384
Dividends declared on common stock   (10,897)         (10,897)           (10,897)
Distributions to non-controlling interests                     (7,195)   (7,195)
Repurchase of non-controlling interests                     (4,504)   (4,504)
Investments made by minority shareholders in consolidated affiliates                     488   488
Comprehensive income:                          
Net income (loss)   (10,806)         (10,806)       12,773   1,967
Other comprehensive income (loss)   (1,673)             (1,673)       (1,673)
Comprehensive income   (12,479)                 12,773   294
Balance, end of period at Dec. 31, 2019   676,122 172 (51,129) 188,471   541,890   (3,282)   129,961   806,083
Increase (Decrease) in Stockholders' Equity                          
Purchase of shares of common stock   (8,327)   (8,327)                 (8,327)
Stock-based compensation   5,603     5,603           309   5,912
Dividends declared on common stock   (10,867)         (10,867)           (10,867)
Distributions to non-controlling interests                     (12,378)   (12,378)
Repurchase of non-controlling interests   (5,020)     (5,020)           (23,919)   (28,939)
Investments made by minority shareholders in consolidated affiliates   (1,300)     (1,300)           1,300    
Comprehensive income:                          
Net income (loss)   (14,122)         (14,122)       13,414   (708)
Other comprehensive income (loss)   3,560             3,560       3,560
Comprehensive income   (10,562)                 13,414   2,852
Balance, end of period at Dec. 31, 2020   $ 645,649 $ 172 $ (59,456) $ 187,754   $ 516,901   $ 278   $ 108,687   $ 754,336